Trade Mark Journal No.2026/031 31 July 2026
WO0000001928731 (40,42)
Office of origin: Switzerland
Date of International Registration:24 April 2026
Date of designation in the UK:
24 April 2026
International priority date claimed: 23 April 2026
(Switzerland)
(847679)
- Class 40
- Consulting services for the custom manufacturing of pharmaceuticals and biologics.
- Class 42
- Pharmaceutical product development services; Pharmaceutical research and development; scientific laboratory services; scientific and technological services, namely biological research and analysis; research and research services in the field of the transfer of biological molecules into living cells, the integration of foreign nucleic acids into the genome of living cells, and transient protein expression; scientific research services for third parties in the field of biochemistry; design and development of computer hardware and software; development and research on new products for third parties; product development for third parties; product development consulting; product research and development; consulting in the field of information technology; consulting in the field of computer software; technology consulting regarding computer hardware and software systems to facilitate their selection, implementation, and use; custom engineering services for third parties in the field of chemical and biological process and plant engineering; technology services aimed at creating custom production capabilities, technologies, market selection, and portfolio composition for the life sciences and pharmaceutical industries; technology services aimed at creating scientific, technological, and digital ecosystems for third parties in the life sciences and pharmaceutical industries.
Lonza Ltd.
Representative: von Arx Schmidiger Faber Rechtsanwälte, Neumarkt 15, CH-8405 Winterthur, SWITZERLAND